Question 1

What specific tumors does this imaging help identify?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors clinical trial (NCT05563272). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this imaging compare to other imaging methods I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors clinical trial (NCT05563272). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of 89Zr-girentuximab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors clinical trial (NCT05563272). Contact the study team or your healthcare provider for specific answers.

Question 4

How will this imaging affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors clinical trial (NCT05563272). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors clinical trial (NCT05563272). Contact the study team or your healthcare provider for specific answers.

Question 6

How often will I need to come in for visits during this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors clinical trial (NCT05563272). Contact the study team or your healthcare provider for specific answers.

What this study is about